Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Changes in iron metabolism and oxidative stress markers after intravenous iron in hemodialysis patients
jRCT1090220139Unknown
- Sponsor
- Shigeru Miyazaki
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of iron sucrose in end-stage kidney disease (ESKD) and iron deficiency anemia (IDA), sponsored by Shigeru Miyazaki. Primary endpoint: Change of iron metabolism markers. Status: unknown.
02
Drugs
iron sucrose
03
Conditions
end-stage kidney disease (ESKD)iron deficiency anemia (IDA)
Beyond the preview
Go deeper on jRCT1090220139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1090220139.